Floatz logo

ar-42

Stage III Adult Diffuse Mixed Cell Lymphoma

Amir MortazaviSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Stage III Adult Diffuse Mixed Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Fludarabine
Case Comprehensive Cancer Center
Phase 2BBB
Cyclophosphamide
University of Chicago
Phase 2BBB
Monomethyl Fumarate
University of Nebraska
Phase 2BB
CYCLOSPORIN A
National Cancer Institute (NCI)
Phase 2BB
TACROLIMUS
National Cancer Institute (NCI)
Phase 2BB

View all 49 →

Same molecule, other indications

ar-42 is also rated in:

plasma cell myelomaDormant
CCC
Indicative ·
52 / 100
View asset →
primary cutaneous B-cell lymphomaDormant
CC
Indicative ·
47 / 100
View asset →
plasma cell myelomaDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →